209 related articles for article (PubMed ID: 31686864)
1. MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway.
Lv Z; Ma J; Wang J; Lu J
Onco Targets Ther; 2019; 12():8501-8513. PubMed ID: 31686864
[TBL] [Abstract][Full Text] [Related]
2. miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma.
Gao G; Tian Z; Zhu HY; Ouyang XY
Cancer Cell Int; 2018; 18():210. PubMed ID: 30574019
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.
Li C; Yu S; Wu S; Ni Y; Pan Z
Onco Targets Ther; 2019; 12():5311-5322. PubMed ID: 31371979
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway.
Fan HP; Wang SY; Shi YY; Sun J
Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3661-3669. PubMed ID: 34109575
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN-AKT Pathway Output.
Li B; Zhao J; Zhao Q; Wu D; Zhang C; Zhao K; Song Y; Gao C
Onco Targets Ther; 2019; 12():9795-9807. PubMed ID: 31814737
[TBL] [Abstract][Full Text] [Related]
6. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
Lv L; Wang X; Ma T
Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
[No Abstract] [Full Text] [Related]
7. microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.
Jia J; Wang J; Yin M; Liu Y
Onco Targets Ther; 2019; 12():5437-5448. PubMed ID: 31360068
[TBL] [Abstract][Full Text] [Related]
8. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
10. Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p.
Liu Y; Li G; Zhang Y; Li L; Zhang Y; Huang X; Wei X; Zhou P; Liu M; Zhao G; Feng J; Wang G
Cancer Cell Int; 2022 Aug; 22(1):252. PubMed ID: 35953862
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET.
Li X; Sun X; Wu J; Li Z
Am J Cancer Res; 2016; 6(12):2869-2879. PubMed ID: 28042506
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.
Gao LF; Jia S; Zhang QM; Xia YF; Li CJ; Li YH
Clin Transl Oncol; 2022 Feb; 24(2):266-275. PubMed ID: 34318428
[TBL] [Abstract][Full Text] [Related]
14. microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting
Ren J; Yang M; Xu F; Chen J
Am J Cancer Res; 2019; 9(1):36-52. PubMed ID: 30755810
[TBL] [Abstract][Full Text] [Related]
15. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
Fan L; Cao X; Lei Y
Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
[TBL] [Abstract][Full Text] [Related]
17. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2.
Sun L; Wang P; Zhang Z; Zhang K; Xu Z; Li S; Mao J
Oncol Lett; 2020 Nov; 20(5):226. PubMed ID: 32968448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
